Floatz logo

SODIUM ZIRCONIUM CYCLOSILICATE

Ascites

Emma NilssonSmall moleculePhase 2Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
29/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Ascites cohort.

Asset / SponsorPhaseRating
NORMAL HUMAN SERUM ALBUMIN
Centro Medico Issemym
Phase 4BBB
Tolvaptan
Konkuk University Medical Center
Phase 4BBB
Rifaximin
Centre Hospitalier Universitaire de Besancon
Phase 4BB
FUROSEMIDE
University of Palermo
Phase 4BB
Spironolactone
University of Padova
Phase 4BB

View all 36 →

Same molecule, other indications

SODIUM ZIRCONIUM CYCLOSILICATE is also rated in:

Metabolic SyndromeDormant
B
Indicative ·
57 / 100
View asset →
HypertensionDormant
CCC
Indicative ·
54 / 100
View asset →
Duchenne Muscular DystrophyDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →